Sandoz Files Anti-Dumping Complaint on Chinese Amoxicillin

Sandoz (SIX:SDZ) lodged a draft anti‑dumping complaint with the European Commission against Chinese amoxicillin imports.
The firm claims it is Europe’s sole major vertically integrated penicillin producer, citing China’s below‑cost pricing and subsidies.
CEO Richard Saynor warned that up to 90% of global antibiotic active ingredients are now produced outside Europe, risking supply security.
He called safeguarding antibiotic supply an economic security and strategic trade issue requiring immediate European action.